Cornerstone Capital, Inc. Durect Corp Transaction History

Cornerstone Capital, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 08, 2018	SELL	$0.91 - $2.24 $21,840 - $53,760	-24,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$0.78 - $2.1 $7,800 - $21,000	10,000 Added 71.43%	24,000 $22,000
Q3 2017 Nov 13, 2017	BUY	$1.55 - $1.82 $21,700 - $25,480	14,000	14,000 $25,000

591K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $282M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Cornerstone Capital, Inc. with notifications on news.